[go: up one dir, main page]

GB0522671D0 - Spisulosine compounds for use in cancer therapy - Google Patents

Spisulosine compounds for use in cancer therapy

Info

Publication number
GB0522671D0
GB0522671D0 GB0522671A GB0522671A GB0522671D0 GB 0522671 D0 GB0522671 D0 GB 0522671D0 GB 0522671 A GB0522671 A GB 0522671A GB 0522671 A GB0522671 A GB 0522671A GB 0522671 D0 GB0522671 D0 GB 0522671D0
Authority
GB
United Kingdom
Prior art keywords
cancer therapy
spisulosine
compounds
spisulosine compounds
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0522671A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Priority to GB0522671A priority Critical patent/GB0522671D0/en
Publication of GB0522671D0 publication Critical patent/GB0522671D0/en
Ceased legal-status Critical Current

Links

GB0522671A 2005-11-08 2005-11-08 Spisulosine compounds for use in cancer therapy Ceased GB0522671D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0522671A GB0522671D0 (en) 2005-11-08 2005-11-08 Spisulosine compounds for use in cancer therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0522671A GB0522671D0 (en) 2005-11-08 2005-11-08 Spisulosine compounds for use in cancer therapy

Publications (1)

Publication Number Publication Date
GB0522671D0 true GB0522671D0 (en) 2005-12-14

Family

ID=35516471

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0522671A Ceased GB0522671D0 (en) 2005-11-08 2005-11-08 Spisulosine compounds for use in cancer therapy

Country Status (1)

Country Link
GB (1) GB0522671D0 (en)

Similar Documents

Publication Publication Date Title
IL190882A0 (en) Compositions for cancer therapy
HUE054365T2 (en) Boronophthalides for therapeutic use
IL186662A0 (en) Combination cancer therapy with
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
HUE037109T2 (en) Endoxifen for use in the treatment of cancer
HK1110224A1 (en) Therapeutic agent for cancer
GB0400700D0 (en) Compounds useful in therapy
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
PT1830847E (en) Treatment for cancer
HK1151971A1 (en) Compounds for use in the treatment of cancer
GB0428187D0 (en) Cancer treatment
GB0504206D0 (en) Combination therapy
GB0509052D0 (en) Combination therapy
GB0522671D0 (en) Spisulosine compounds for use in cancer therapy
GB0404675D0 (en) Cancer treatment
GB0516610D0 (en) Compounds for use in therapy
GB0507685D0 (en) Cancer treatment
GB0604794D0 (en) Spisulosine compounds for use in cancer therapy
GB0515900D0 (en) Compounds for use in therapy
GB0510814D0 (en) Compounds for use in therapy
GB0510815D0 (en) Compounds for use in therapy
GB0423117D0 (en) Compounds for use in therapy
GB0427826D0 (en) Compounds for use in therapy
GB0614970D0 (en) Compounds For Use In Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)